CompaniesAnnias Immunotherapeutics

Annias Immunotherapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

57

By Phase

PHASE1: 2

By Status

ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT02864368
NCT03299309
Hover over trial bars to see details

Recent Trials

NCT03299309Collaborator
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
PHASE1Active, not recruiting
30 participants
Started: Jun 29, 2018 · Completed: Apr 30, 2026
NCT02864368Collaborator
Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens
PHASE1Terminated
27 participants
Started: Dec 7, 2016 · Completed: Jun 15, 2020